Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden

INTRODUCTION: The use of proton therapy increases globally despite a lack of randomised controlled trials demonstrating its efficacy and safety. Proton therapy enables sparing of non-neoplastic tissue from radiation. This is principally beneficial and holds promise of reduced long-term side effects....

Descripción completa

Detalles Bibliográficos
Autores principales: Heggebø, Liv Cathrine, Borgen, Ida Maria Henriksen, Rylander, Hillevi, Kiserud, Cecilie, Nordenmark, Tonje Haug, Hellebust, Taran Paulsen, Evensen, Morten Egeberg, Gustavsson, Magnus, Ramberg, Christina, Sprauten, Mette, Magelssen, Henriette, Blakstad, Hanne, Moorthy, Janani, Andersson, Karin, Raunert, Ingela, Henry, Thomas, Moe, Cecilie, Granlund, Carin, Goplen, Dorota, Brekke, Jorunn, Johannessen, Tor-Christian Aase, Solheim, Tora Skeidsvoll, Marienhagen, Kirsten, Humberset, Øyvind, Bergström, Per, Agrup, Måns, Dahl, Ludvig, Gubanski, Michael, Gojon, Helene, Brahme, Carl-Johan, Rydén, Isabelle, Jakola, Asgeir S, Vik-Mo, Einar O, Lie, Hanne C., Asphaug, Lars, Hervani, Maziar, Kristensen, Ingrid, Rueegg, Corina Silvia, Olsen, Inge C, Ledal, Rolf J, Degsell, Eskil, Werlenius, Katja, Blomstrand, Malin, Brandal, Petter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030923/
https://www.ncbi.nlm.nih.gov/pubmed/36940951
http://dx.doi.org/10.1136/bmjopen-2022-070071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030923/
https://www.ncbi.nlm.nih.gov/pubmed/36940951
http://dx.doi.org/10.1136/bmjopen-2022-070071

Ejemplares similares